Vertex Pharmaceuticals Incorporated (VRTX) Profit Margins
Over the twelve months to 2026-06-30, Vertex Pharmaceuticals Incorporated (VRTX) had gross margin 86.0%, operating margin 38.0%, net margin 35.0%, free cash flow margin 30.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VRTXVertex Pharmaceuticals IncorporatedFollow VRTX — free
—
Price chart with a free account
- Market cap
- 132.8B
- P/E TTM
- 30.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 95.5% | 84.5% | 92.7% | 93.2% | 88.7% | 87.9% | 89.0% | 86.6% | 86.8% | 88.1% | 88.1% | 87.9% | 87.2% | 86.1% | 86.2% | 86.0% | |
| Operating margin | -485.5% | 8.1% | 3.1% | -50.3% | -119.3% | -45.2% | 0.6% | 5.0% | 20.8% | 28.8% | 46.0% | 36.7% | 48.2% | 38.8% | -2.1% | 34.8% | 38.0% | |
| Net margin | -526.3% | 2.1% | -7.0% | -36.7% | -127.2% | -53.9% | -6.6% | 10.6% | 68.8% | 28.3% | 43.7% | 30.9% | 37.2% | 36.7% | -4.9% | 32.9% | 35.0% | |
| FCF margin | -469.8% | 7.7% | 12.9% | -9.2% | -107.6% | -39.8% | 10.5% | 30.0% | 38.5% | 35.9% | 48.2% | 31.8% | 44.0% | 33.8% | -7.2% | 26.6% | 30.2% |
USD billions · SEC XBRL
Vertex Pharmaceuticals Incorporated — questions
- What is Vertex Pharmaceuticals Incorporated's gross margin?
- 86.0% over the twelve months to 2026-06-30.
- What is Vertex Pharmaceuticals Incorporated's operating margin?
- 38.0% over the twelve months to 2026-06-30.
- What is Vertex Pharmaceuticals Incorporated's net profit margin?
- 35.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Vertex Pharmaceuticals Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.